Press release
Cardiac Marker Analyzer Product Analysis 2022: Key Major Players are Alere, Abbott Point of Care, Roche, Beckman Coulter, Siemens Healthineers, Response Biomedical, Boditech, Lifesign, LSI Medience Corporation, CardioGenics Holdings Inc. & Trinity Biotech
Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.Access Full Report @ http://www.marketreportsonline.com/647096.html.
Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others.
The factors such as increasing incidences of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market.
Key Highlights of the Report:
Within the professional diagnostics business segment, Alere cardiometabolic net product sales and services revenue decreased by 12% in 2016.
In April 2017, Abbott and Alere Inc. announced that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere.
In 2016, Abbott Point of Care Diagnostics sales increased to over US$ 500 Million.
Cobas H232 POC system permits rapid and easy determination of cardiac blood markers such as Troponin T, NT-proBNP, D-dimer, CK-MB and myoglobin.
A major focus of Response Biomedical development programs in cardiovascular testing has been clinical tests for the quantification of cardiovascular markers.
In February 2017, Siemens Healthineers announced a digital platform for healthcare providers as well as for providers of solutions and services.
Response Biomedical cardiovascular sales is likely to reach US$ XX Million by 2022.
Trinity Biotech Point-of-Care revenues for 2017 is likely to decline.
In Jan. 2017, Abbott completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena.
Purchase a copy of this “Cardiac Marker Analyzer Product Market” report @ http://www.marketreportsonline.com/contacts/purchase.php?name=647096.
Cardiac Marker Analyzer - Key Companies Analysis: Alere, Abbott Point of Care, Roche, Beckman Coulter, Siemens Healthineers, Response Biomedical, Boditech, Lifesign, LSI Medience Corporation, CardioGenics Holdings Inc. & Trinity Biotech
“Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy” provides a comprehensive assessment of the cardiac markers analyzer segments, comparative tests analysis, competitive product analysis, product features & benefits, merger, acquisitions, strategic alliances and Companies Business and Market Strategies.
This 100 Page report with 7 Figures and 18 Tables has been studied from 6 View Points:
1. Cardiac Marker Companies - Comparative Tests Analysis
2. Cardiac Marker Analyzer - Competitive Product Analysis
3. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
4. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
5. Emerging Markers Analysis
6. Companies Business & Marketing Strategy
This 100 Page report with 7 Figures and 18 Tables has been studied from 6 View Points:
• Cardiac Marker Companies - Comparative Tests Analysis
• Cardiac Marker Analyzer - Competitive Product Analysis
• Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
• Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
• Emerging Markers Analysis
• Companies Business & Marketing Strategy
Browse all latest medical devices market research reports @ http://www.marketreportsonline.com/cat/medical-devices-market-research.html.
About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.
Contact Us:
Vishal Kalra
Tel: + 1 888 391 5441
Email: sales@marketreportsonline.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Marker Analyzer Product Analysis 2022: Key Major Players are Alere, Abbott Point of Care, Roche, Beckman Coulter, Siemens Healthineers, Response Biomedical, Boditech, Lifesign, LSI Medience Corporation, CardioGenics Holdings Inc. & Trinity Biotech here
News-ID: 1504085 • Views: …
More Releases from MarketReportsOnline
US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is…
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,…
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.…
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021.
The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
